Report Detail
Global Human Growth Hormone Drugs Market Insights, Forecast to 2025
- RnM2349711 |
- 13 July, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Human Growth Hormone Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Growth Hormone Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Growth Hormone Drugs market is segmented into
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Segment by Application, the Human Growth Hormone Drugs market is segmented into
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Regional and Country-level Analysis
The Human Growth Hormone Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Growth Hormone Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Growth Hormone Drugs Market Share Analysis
Human Growth Hormone Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Growth Hormone Drugs business, the date to enter into the Human Growth Hormone Drugs market, Human Growth Hormone Drugs product introduction, recent developments, etc.
The major vendors covered:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
1 Study Coverage
- 1.1 Human Growth Hormone Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Human Growth Hormone Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Type
- 1.4.2 Norditropin
- 1.4.3 Genotropin
- 1.4.4 Humatrope
- 1.4.5 Saizen
- 1.4.6 Omnitrope - the Somatropin Biosimilar
- 1.4.7 Somatropin Biopartners
- 1.5 Market by Application
- 1.5.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Application
- 1.5.2 Prader-Willi Syndrome
- 1.5.3 Turner Syndrome
- 1.5.4 Short Stature Homeobox Gene
- 1.5.5 Small for Gestational Age
- 1.5.6 Chronic Renal Insufficiency
- 1.5.7 Short Bowel Syndrome
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Human Growth Hormone Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Human Growth Hormone Drugs Revenue 2015-2026
- 2.1.2 Global Human Growth Hormone Drugs Sales 2015-2026
- 2.2 Global Human Growth Hormone Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Human Growth Hormone Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Human Growth Hormone Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Growth Hormone Drugs Competitor Landscape by Players
- 3.1 Human Growth Hormone Drugs Sales by Manufacturers
- 3.1.1 Human Growth Hormone Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Human Growth Hormone Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Human Growth Hormone Drugs Revenue by Manufacturers
- 3.2.1 Human Growth Hormone Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Human Growth Hormone Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Human Growth Hormone Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Human Growth Hormone Drugs Revenue in 2019
- 3.2.5 Global Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Human Growth Hormone Drugs Price by Manufacturers
- 3.4 Human Growth Hormone Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Human Growth Hormone Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Human Growth Hormone Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Human Growth Hormone Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Human Growth Hormone Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Human Growth Hormone Drugs Sales by Type (2015-2020)
- 4.1.2 Global Human Growth Hormone Drugs Revenue by Type (2015-2020)
- 4.1.3 Human Growth Hormone Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Human Growth Hormone Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Human Growth Hormone Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Human Growth Hormone Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Human Growth Hormone Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Human Growth Hormone Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Human Growth Hormone Drugs Sales by Application (2015-2020)
- 5.1.2 Global Human Growth Hormone Drugs Revenue by Application (2015-2020)
- 5.1.3 Human Growth Hormone Drugs Price by Application (2015-2020)
- 5.2 Human Growth Hormone Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Human Growth Hormone Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Human Growth Hormone Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Human Growth Hormone Drugs by Country
- 6.1.1 North America Human Growth Hormone Drugs Sales by Country
- 6.1.2 North America Human Growth Hormone Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Human Growth Hormone Drugs Market Facts & Figures by Type
- 6.3 North America Human Growth Hormone Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Human Growth Hormone Drugs by Country
- 7.1.1 Europe Human Growth Hormone Drugs Sales by Country
- 7.1.2 Europe Human Growth Hormone Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Human Growth Hormone Drugs Market Facts & Figures by Type
- 7.3 Europe Human Growth Hormone Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Human Growth Hormone Drugs by Region
- 8.1.1 Asia Pacific Human Growth Hormone Drugs Sales by Region
- 8.1.2 Asia Pacific Human Growth Hormone Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Human Growth Hormone Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Human Growth Hormone Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Human Growth Hormone Drugs by Country
- 9.1.1 Latin America Human Growth Hormone Drugs Sales by Country
- 9.1.2 Latin America Human Growth Hormone Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Human Growth Hormone Drugs Market Facts & Figures by Type
- 9.3 Central & South America Human Growth Hormone Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Human Growth Hormone Drugs by Country
- 10.1.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country
- 10.1.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Human Growth Hormone Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Human Growth Hormone Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Eli Lilly and Company (US)
- 11.1.1 Eli Lilly and Company (US) Corporation Information
- 11.1.2 Eli Lilly and Company (US) Description and Business Overview
- 11.1.3 Eli Lilly and Company (US) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Products Offered
- 11.1.5 Eli Lilly and Company (US) Related Developments
- 11.2 Ferring Holding SA (Switzerland)
- 11.2.1 Ferring Holding SA (Switzerland) Corporation Information
- 11.2.2 Ferring Holding SA (Switzerland) Description and Business Overview
- 11.2.3 Ferring Holding SA (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Products Offered
- 11.2.5 Ferring Holding SA (Switzerland) Related Developments
- 11.3 Genentech, Inc. (US)
- 11.3.1 Genentech, Inc. (US) Corporation Information
- 11.3.2 Genentech, Inc. (US) Description and Business Overview
- 11.3.3 Genentech, Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Products Offered
- 11.3.5 Genentech, Inc. (US) Related Developments
- 11.4 GeneScience Pharmaceuticals Co., Ltd. (China)
- 11.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
- 11.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Description and Business Overview
- 11.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Products Offered
- 11.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Related Developments
- 11.5 Merck KgaA (Germany)
- 11.5.1 Merck KgaA (Germany) Corporation Information
- 11.5.2 Merck KgaA (Germany) Description and Business Overview
- 11.5.3 Merck KgaA (Germany) Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Products Offered
- 11.5.5 Merck KgaA (Germany) Related Developments
- 11.6 Novo Nordisk A/S (Denmark)
- 11.6.1 Novo Nordisk A/S (Denmark) Corporation Information
- 11.6.2 Novo Nordisk A/S (Denmark) Description and Business Overview
- 11.6.3 Novo Nordisk A/S (Denmark) Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Products Offered
- 11.6.5 Novo Nordisk A/S (Denmark) Related Developments
- 11.7 Pfizer, Inc. (US)
- 11.7.1 Pfizer, Inc. (US) Corporation Information
- 11.7.2 Pfizer, Inc. (US) Description and Business Overview
- 11.7.3 Pfizer, Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Products Offered
- 11.7.5 Pfizer, Inc. (US) Related Developments
- 11.8 Sandoz International GmbH (Germany)
- 11.8.1 Sandoz International GmbH (Germany) Corporation Information
- 11.8.2 Sandoz International GmbH (Germany) Description and Business Overview
- 11.8.3 Sandoz International GmbH (Germany) Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Products Offered
- 11.8.5 Sandoz International GmbH (Germany) Related Developments
- 11.1 Eli Lilly and Company (US)
- 11.1.1 Eli Lilly and Company (US) Corporation Information
- 11.1.2 Eli Lilly and Company (US) Description and Business Overview
- 11.1.3 Eli Lilly and Company (US) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Products Offered
- 11.1.5 Eli Lilly and Company (US) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Human Growth Hormone Drugs Market Estimates and Projections by Region
- 12.1.1 Global Human Growth Hormone Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Human Growth Hormone Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Human Growth Hormone Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Human Growth Hormone Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Human Growth Hormone Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Human Growth Hormone Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Human Growth Hormone Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Human Growth Hormone Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Human Growth Hormone Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Human Growth Hormone Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Human Growth Hormone Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Human Growth Hormone Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Human Growth Hormone Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Human Growth Hormone Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Human Growth Hormone Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Human Growth Hormone Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Human Growth Hormone Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Human Growth Hormone Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Human Growth Hormone Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Human Growth Hormone Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Human Growth Hormone Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Human Growth Hormone Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Human Growth Hormone Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Human Growth Hormone Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Human Growth Hormone Drugs . Industry analysis & Market Report on Human Growth Hormone Drugs is a syndicated market report, published as Global Human Growth Hormone Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Human Growth Hormone Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
